Viral Infections
RSSArticles
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
Fluvoxamine Reduces the Risk for Hospitalization from COVID-19
Researchers found fluvoxamine (100 mg twice a day for 10 days) lowered the risk for hospitalization among high-risk outpatients diagnosed with COVID-19.
-
WHO: Corticosteroids OK for Children with Multisystem Inflammatory Syndrome
International group updates guidelines for treating young patients with this rare-but-serious COVID-19-related complication.
-
COVID-19 Vaccination, Pregnancy, Lactation, and Fertility
Vaccination rates are notably low among pregnant women. Clinicians should underscore the safety of vaccination and the risks of natural infection, particularly in pregnancy and in patients with underlying comorbidities.
-
Homelessness and COVID-19
Extra screening in care for homeless persons can help solve many problems, including the administration of COVID-19 vaccination to this vulnerable population.
-
Resistance Erodes Standard Treatment for Pneumonia
These data suggest community-acquired pneumonia CAP therapy may no longer be relevant for many patients with CAP, and the required use of the current CAP bundle with limited antibacterial therapy choices should be re-assessed.
-
Regulators Sign Off on COVID-19 Vaccine ‘Mix and Match’
Federal agencies expand, clarify guidance on booster shots.
-
Adjuvanted Zoster Vaccine: Persistent Protection
The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.
-
Study: Interferon Does Not Help Hospitalized COVID-19 Patients
When combined with remdesivir, the multiple sclerosis drug did not produce clinical benefit.
-
SARS-CoV-2 Rapid Antigen Testing in a Nursing Home Outbreak
Rapid antigen testing was accurate in detecting SARS-CoV-2 antigen when compared to polymerase chain reaction.